HEAR FEATURED PRESENTATIONS FROM:

Li Chen, Ph.D., Head of Research, CSO, Roche R&D Center (China) Limited

Eric Morfin, PMP, Director, Project Management Office, Novartis Vaccines and Diagnostics

Mao Mao, M.D., Ph.D., Associate Director/China Project Liaison, Oncology Clinical Research, Merck Research Laboratories

Thomas Hooker Bliss, Jr., Director of Licensing, Amgen Inc.

Suresh Poosala, D.V.M., M.S., Ph.D., Chief of Comparative Medicine and Animal Program Director, NIA/NIH

• Protecting IP & Understanding Barriers and Trends

• Understanding the Regulatory Landscape of China

• Approaches for Accessing Talent and Leveraging Resources

• Best Practices for Building an Integrative R&D Service Company in China

• Building Partnerships with Academia and Biopharma Companies

• Strategies for Integrating a Western Management Style toEastern Drug Development

• Leverage China’s Cultural Differences to more EfficientlyManage your Preclinical and Clinical Studies

• Simple Ways to Establish Preclinical Testing Facilities

“*Special Tianjin Government Presentation:
A Government and Local Industry Perspective on Developing an R&D Center in China”

FEATURING PERSPECTIVES, STRATEGIES, & CASE STUDIES FROM:

Amgen, Inc.  |  Applied Biosystems, Inc.  |  Ascenta Therapeutics, Inc.  |  AstraZeneca China | Bridge Pharmaceuticals, Inc.  |  Excel Pharma Studies,Inc.  |  Genzyme Corporation  |  GNI Ltd. | Hong Kong Science Park  |  Hutchison MediPharma  |  Jones Day (Shanghai and USA) | Merck Research Laboratories  |  National Institutes of Health (NIH)  |  Novartis Vaccines and Diagnostics  |  Roche R&D Center (China) Limited  |  Shanghai Genomics, Inc.  |  Sino Biopharmaceuticals, Ltd.  |  The University of Hong Kong  |  WuXi PharmaTech  |  Wyeth Research Labs